Shinji Okabayashi Selected Research

Shinji Okabayashi Research Topics

10	Ulcerative Colitis 10/2023 - 01/2017
2	Crohn Disease (Crohn's Disease) 08/2019 - 01/2018
2	Inflammation (Inflammations) 10/2017 - 01/2017
1	Necrosis 01/2022
1	Leukopenia 11/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Pulmonary Aspergillosis 07/2021
1	Neoplasms (Cancer) 07/2021
1	Abscess 11/2018
1	Pulmonary Tuberculosis 01/2018
1	Ulcer 10/2017
1	Enteritis 10/2017

3	Mesalamine (Mesalazine)FDA LinkGeneric 08/2021 - 01/2019
3	Capsules (Microcapsules)IBA 04/2021 - 10/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 01/2018
2	Certolizumab Pegol FDA Link 01/2022 - 08/2019
2	SteroidsIBA 01/2022 - 10/2017
2	TabletsIBA 07/2020 - 01/2019
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2018 - 01/2017
1	Immunologic Factors (Immunomodulators)IBA 10/2023
1	NucleotidesIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Diphosphates (Pyrophosphates)IBA 11/2021
1	2-mercaptopurineIBA 11/2021
1	AntibodiesIBA 07/2021
1	Immunoglobulin G (IgG)IBA 07/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2019
1	Cytochrome P-450 CYP3AIBA 04/2019
1	MucinsIBA 11/2018
1	Adalimumab (Humira)FDA Link 10/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017

2	Remission Induction 08/2019 - 01/2017
1	Therapeutics 01/2018